GLP-1 Innovations: Weight Loss & Muscle Preservation in Medicine

This presentation examines the metabolic and physical impacts of GLP-1 receptor agonists, SGLT2 inhibitors, and metformin in diabetes management. It explores their mechanisms, weight effects, and muscle mass considerations, leveraging data from clinical cases and secondary analyses. The session emphasizes balancing weight loss with muscle preservation, providing insights into personalized care strategies and implications for future drug development. Tailored for healthcare providers, this...